Clin2
NCT03004326Possibly a fitRecruiting

Biopsy study to test skin inflammation gene signals

Cryoglobulinemic Vasculitis (CV)Drug-induced VasculitisEosinophilic Granulomatosis With Polyangiitis (EGPA)IgA VasculitisIsolated Cutaneous VasculitisGranulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)Polyarteritis Nodosa (PAN)

Part of Blood & lymphatic, Brain & nervous system, Heart & circulation, Immune system & allergy, Lungs & breathing, Skin clinical trials.

This study uses a skin biopsy to look at “gene signals” (transcriptomics) in patients with active vasculitis that shows up on the skin. It may help researchers understand what is happening in your disease and how different types of vasculitis differ.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
5 years and older
Study type
Observational

Who can take part

  • You have an active skin lesion that your doctor thinks is from vasculitis (for example purplish spots, raised/palpable bruiselike areas, nodules, ulcers, or painful hive-like patches).
  • Your vasculitis is one of these types: cryoglobulinemic vasculitis, drug-induced vasculitis, EGPA, IgA vasculitis, isolated cutaneous vasculitis, GPA, microscopic polyangiitis, PAN, or urticarial vasculitis.
  • You are willing and able to sign written consent (or have a legal guardian provide consent if needed).
  • You can safely have a skin biopsy—your doctor does not think the biopsy risk is too high for you (like infection/bleeding risk).
  • Your blood counts are high enough: neutrophils 1500/mm³ or more, platelets 50,000/mm³ or more, and hemoglobin 7 g/dL or more.
  • You are not pregnant or nursing, and you do not have an active infection near where the biopsy would be taken.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05383339Recruiting
Testing blood markers in autoimmune, vasculitis, and autoinflammation

This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.

Paris, France
NCT05565885Recruiting
Blood test study to find markers in adult vasculitis

This study looks for blood test markers that may help diagnose vasculitis and predict how it may go. You may be offered additional blood sampling if you have certain active vasculitis conditions.

Tours
NCT04006535Recruiting
Genetic testing study for vasculitis in families and children

This study uses a detailed DNA test to look for possible genetic causes of vasculitis (inflammation of blood vessels) in children and adults. It may help researchers better understand why vasculitis happens, especially in families.

Paris, Île-de-France Region
NCT02593565Recruiting
Pregnancy blood-vessel disease registry study

This is a pregnancy registry that collects information from people with certain blood-vessel inflammatory diseases during pregnancy. It helps researchers better understand these conditions in pregnancy and may guide future care.

Tampa, Florida
NCT02939573Recruiting· Phase 2
Study of medicines for skin-only vasculitis flares

This Phase 2 trial tests different medicines to calm active skin vasculitis and prevent flare-ups. It’s for people whose vasculitis mainly affects the skin, not major organs like kidneys or the brain.

Kansas City, Kansas
NCT02967068Recruiting
Share your study tissue for future research

This study is a “tissue repository” that collects and stores leftover tissue from other approved VCRC studies. If you already took part in one of those studies, you may be able to let researchers use your tissue to help answer future questions.

Boston, Massachusetts

Hear when a new Eosinophilic Granulomatosis With Polyangiitis (EGPA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.